Solidagenone from <i>Solidago chilensis</i> Meyen Protects against Acute Peritonitis and Lipopolysaccharide-Induced Shock by Regulating NF-κB Signaling Pathway

Anti-inflammatory agents are widely used for the treatment of inflammatory diseases. Nevertheless, the associated side effects of the available drugs make it necessary to search for new anti-inflammatory drugs. Here, we investigated the anti-inflammatory activity of solidagenone. Initially, we obser...

Full description

Bibliographic Details
Main Authors: Ivanilson Pimenta Santos, Laís Peres Silva, Dahara Keyse Carvalho Silva, Bruna Padilha Zurita Claro dos Reis, Temistocles Barroso de Oliveira, Andressa Maia Kelly, Edivaldo dos Santos Rodrigues, Claudia Valeria Campos de Souza, José Fernando Oliveira-Costa, Simone Sacramento Valverde, Osvaldo Andrade Santos-Filho, Milena Botelho Pereira Soares, Cássio Santana Meira
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/17/3/273
_version_ 1827305326255276032
author Ivanilson Pimenta Santos
Laís Peres Silva
Dahara Keyse Carvalho Silva
Bruna Padilha Zurita Claro dos Reis
Temistocles Barroso de Oliveira
Andressa Maia Kelly
Edivaldo dos Santos Rodrigues
Claudia Valeria Campos de Souza
José Fernando Oliveira-Costa
Simone Sacramento Valverde
Osvaldo Andrade Santos-Filho
Milena Botelho Pereira Soares
Cássio Santana Meira
author_facet Ivanilson Pimenta Santos
Laís Peres Silva
Dahara Keyse Carvalho Silva
Bruna Padilha Zurita Claro dos Reis
Temistocles Barroso de Oliveira
Andressa Maia Kelly
Edivaldo dos Santos Rodrigues
Claudia Valeria Campos de Souza
José Fernando Oliveira-Costa
Simone Sacramento Valverde
Osvaldo Andrade Santos-Filho
Milena Botelho Pereira Soares
Cássio Santana Meira
author_sort Ivanilson Pimenta Santos
collection DOAJ
description Anti-inflammatory agents are widely used for the treatment of inflammatory diseases. Nevertheless, the associated side effects of the available drugs make it necessary to search for new anti-inflammatory drugs. Here, we investigated the anti-inflammatory activity of solidagenone. Initially, we observed that a single dose of 30, 60, or 90 mg/kg of solidagenone did not result in mortality or elicit any discernible signs of toxicity in mice. At the same doses, solidagenone promoted a significant reduction in the migration of neutrophils in an acute peritonitis model and decreased mortality in a lipopolysaccharide-induced endotoxic shock model. Interestingly, treatment with solidagenone conferred a protective effect against leukopenia and thrombocytopenia, hematological disorders commonly observed in sepsis conditions. In addition, treatment with all the doses of solidagenone promoted a significant reduction in nitric oxide, TNF-α, and IL-1β levels relative to the LPS-stimulated vehicle-treated cultures. Furthermore, gene expression and in silico analyses also supported the modulation of the NF-<i>κ</i>B pathway by solidagenone. Finally, in silico pharmacokinetics predictions indicated a favorable drugability profile for solidagenone. Taken together, the findings of the present investigation show that solidagenone exhibits significant anti-inflammatory properties in acute experimental models, potentially through the modulation of the NF-κB signaling pathway.
first_indexed 2024-04-24T17:56:19Z
format Article
id doaj.art-a55b3832f4bc47aabc52d839a442b1d9
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-04-24T17:56:19Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-a55b3832f4bc47aabc52d839a442b1d92024-03-27T13:59:09ZengMDPI AGPharmaceuticals1424-82472024-02-0117327310.3390/ph17030273Solidagenone from <i>Solidago chilensis</i> Meyen Protects against Acute Peritonitis and Lipopolysaccharide-Induced Shock by Regulating NF-κB Signaling PathwayIvanilson Pimenta Santos0Laís Peres Silva1Dahara Keyse Carvalho Silva2Bruna Padilha Zurita Claro dos Reis3Temistocles Barroso de Oliveira4Andressa Maia Kelly5Edivaldo dos Santos Rodrigues6Claudia Valeria Campos de Souza7José Fernando Oliveira-Costa8Simone Sacramento Valverde9Osvaldo Andrade Santos-Filho10Milena Botelho Pereira Soares11Cássio Santana Meira12Gonçalo Moniz Institute, Oswaldo Cruz Foundation, FIOCRUZ, Salvador 40296-710, BA, BrazilGonçalo Moniz Institute, Oswaldo Cruz Foundation, FIOCRUZ, Salvador 40296-710, BA, BrazilGonçalo Moniz Institute, Oswaldo Cruz Foundation, FIOCRUZ, Salvador 40296-710, BA, BrazilGonçalo Moniz Institute, Oswaldo Cruz Foundation, FIOCRUZ, Salvador 40296-710, BA, BrazilPharmaceutical Technology Institute—FarManguinhos, Natural Products Department, Oswaldo Cruz Foundation, FIOCRUZ, Rio de Janeiro 21041-250, RJ, BrazilPharmaceutical Technology Institute—FarManguinhos, Natural Products Department, Oswaldo Cruz Foundation, FIOCRUZ, Rio de Janeiro 21041-250, RJ, BrazilLaboratory of Molecular Modeling and Computational Structural Biology, Natural Products Research Institute, Health Sciences Center, Federal University of Rio de Janeiro, Rio de Janeiro 21941-599, RJ, BrazilLaboratory of Molecular Modeling and Computational Structural Biology, Natural Products Research Institute, Health Sciences Center, Federal University of Rio de Janeiro, Rio de Janeiro 21941-599, RJ, BrazilCenter for Infusions and Specialized Medicines of Bahia, Bahia State Health Department, Salvador 41745-900, BA, BrazilPharmaceutical Technology Institute—FarManguinhos, Natural Products Department, Oswaldo Cruz Foundation, FIOCRUZ, Rio de Janeiro 21041-250, RJ, BrazilLaboratory of Molecular Modeling and Computational Structural Biology, Natural Products Research Institute, Health Sciences Center, Federal University of Rio de Janeiro, Rio de Janeiro 21941-599, RJ, BrazilGonçalo Moniz Institute, Oswaldo Cruz Foundation, FIOCRUZ, Salvador 40296-710, BA, BrazilGonçalo Moniz Institute, Oswaldo Cruz Foundation, FIOCRUZ, Salvador 40296-710, BA, BrazilAnti-inflammatory agents are widely used for the treatment of inflammatory diseases. Nevertheless, the associated side effects of the available drugs make it necessary to search for new anti-inflammatory drugs. Here, we investigated the anti-inflammatory activity of solidagenone. Initially, we observed that a single dose of 30, 60, or 90 mg/kg of solidagenone did not result in mortality or elicit any discernible signs of toxicity in mice. At the same doses, solidagenone promoted a significant reduction in the migration of neutrophils in an acute peritonitis model and decreased mortality in a lipopolysaccharide-induced endotoxic shock model. Interestingly, treatment with solidagenone conferred a protective effect against leukopenia and thrombocytopenia, hematological disorders commonly observed in sepsis conditions. In addition, treatment with all the doses of solidagenone promoted a significant reduction in nitric oxide, TNF-α, and IL-1β levels relative to the LPS-stimulated vehicle-treated cultures. Furthermore, gene expression and in silico analyses also supported the modulation of the NF-<i>κ</i>B pathway by solidagenone. Finally, in silico pharmacokinetics predictions indicated a favorable drugability profile for solidagenone. Taken together, the findings of the present investigation show that solidagenone exhibits significant anti-inflammatory properties in acute experimental models, potentially through the modulation of the NF-κB signaling pathway.https://www.mdpi.com/1424-8247/17/3/273solidagenoneinflammationendotoxic shockNF-κB
spellingShingle Ivanilson Pimenta Santos
Laís Peres Silva
Dahara Keyse Carvalho Silva
Bruna Padilha Zurita Claro dos Reis
Temistocles Barroso de Oliveira
Andressa Maia Kelly
Edivaldo dos Santos Rodrigues
Claudia Valeria Campos de Souza
José Fernando Oliveira-Costa
Simone Sacramento Valverde
Osvaldo Andrade Santos-Filho
Milena Botelho Pereira Soares
Cássio Santana Meira
Solidagenone from <i>Solidago chilensis</i> Meyen Protects against Acute Peritonitis and Lipopolysaccharide-Induced Shock by Regulating NF-κB Signaling Pathway
Pharmaceuticals
solidagenone
inflammation
endotoxic shock
NF-κB
title Solidagenone from <i>Solidago chilensis</i> Meyen Protects against Acute Peritonitis and Lipopolysaccharide-Induced Shock by Regulating NF-κB Signaling Pathway
title_full Solidagenone from <i>Solidago chilensis</i> Meyen Protects against Acute Peritonitis and Lipopolysaccharide-Induced Shock by Regulating NF-κB Signaling Pathway
title_fullStr Solidagenone from <i>Solidago chilensis</i> Meyen Protects against Acute Peritonitis and Lipopolysaccharide-Induced Shock by Regulating NF-κB Signaling Pathway
title_full_unstemmed Solidagenone from <i>Solidago chilensis</i> Meyen Protects against Acute Peritonitis and Lipopolysaccharide-Induced Shock by Regulating NF-κB Signaling Pathway
title_short Solidagenone from <i>Solidago chilensis</i> Meyen Protects against Acute Peritonitis and Lipopolysaccharide-Induced Shock by Regulating NF-κB Signaling Pathway
title_sort solidagenone from i solidago chilensis i meyen protects against acute peritonitis and lipopolysaccharide induced shock by regulating nf κb signaling pathway
topic solidagenone
inflammation
endotoxic shock
NF-κB
url https://www.mdpi.com/1424-8247/17/3/273
work_keys_str_mv AT ivanilsonpimentasantos solidagenonefromisolidagochilensisimeyenprotectsagainstacuteperitonitisandlipopolysaccharideinducedshockbyregulatingnfkbsignalingpathway
AT laisperessilva solidagenonefromisolidagochilensisimeyenprotectsagainstacuteperitonitisandlipopolysaccharideinducedshockbyregulatingnfkbsignalingpathway
AT daharakeysecarvalhosilva solidagenonefromisolidagochilensisimeyenprotectsagainstacuteperitonitisandlipopolysaccharideinducedshockbyregulatingnfkbsignalingpathway
AT brunapadilhazuritaclarodosreis solidagenonefromisolidagochilensisimeyenprotectsagainstacuteperitonitisandlipopolysaccharideinducedshockbyregulatingnfkbsignalingpathway
AT temistoclesbarrosodeoliveira solidagenonefromisolidagochilensisimeyenprotectsagainstacuteperitonitisandlipopolysaccharideinducedshockbyregulatingnfkbsignalingpathway
AT andressamaiakelly solidagenonefromisolidagochilensisimeyenprotectsagainstacuteperitonitisandlipopolysaccharideinducedshockbyregulatingnfkbsignalingpathway
AT edivaldodossantosrodrigues solidagenonefromisolidagochilensisimeyenprotectsagainstacuteperitonitisandlipopolysaccharideinducedshockbyregulatingnfkbsignalingpathway
AT claudiavaleriacamposdesouza solidagenonefromisolidagochilensisimeyenprotectsagainstacuteperitonitisandlipopolysaccharideinducedshockbyregulatingnfkbsignalingpathway
AT josefernandooliveiracosta solidagenonefromisolidagochilensisimeyenprotectsagainstacuteperitonitisandlipopolysaccharideinducedshockbyregulatingnfkbsignalingpathway
AT simonesacramentovalverde solidagenonefromisolidagochilensisimeyenprotectsagainstacuteperitonitisandlipopolysaccharideinducedshockbyregulatingnfkbsignalingpathway
AT osvaldoandradesantosfilho solidagenonefromisolidagochilensisimeyenprotectsagainstacuteperitonitisandlipopolysaccharideinducedshockbyregulatingnfkbsignalingpathway
AT milenabotelhopereirasoares solidagenonefromisolidagochilensisimeyenprotectsagainstacuteperitonitisandlipopolysaccharideinducedshockbyregulatingnfkbsignalingpathway
AT cassiosantanameira solidagenonefromisolidagochilensisimeyenprotectsagainstacuteperitonitisandlipopolysaccharideinducedshockbyregulatingnfkbsignalingpathway